Literature DB >> 19509126

CNS regulation of glucose homeostasis.

Carol K L Lam1, Madhu Chari, Tony K T Lam.   

Abstract

The past decade has hosted a remarkable surge in research dedicated to the central control of homeostatic mechanisms. Evidence indicates that the brain, in particular the hypothalamus, directly senses hormones and nutrients to initiate behavioral and metabolic responses to control energy and nutrient homeostasis. Diabetes is chiefly characterized by hyperglycemia due to impaired glucose homeostatic regulation, and a primary therapeutic goal is to lower plasma glucose levels. As such, in this review, we highlight the role of the hypothalamus in the regulation of glucose homeostasis in particular and discuss the cellular and molecular mechanisms by which this neural pathway is orchestrated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19509126     DOI: 10.1152/physiol.00003.2009

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  37 in total

Review 1.  Homeostastic and non-homeostatic functions of melanocortin-3 receptors in the control of energy balance and metabolism.

Authors:  Karima Begriche; Gregory M Sutton; Andrew A Butler
Journal:  Physiol Behav       Date:  2011-04-13

2.  Activation of N-methyl-D-aspartate (NMDA) receptors in the dorsal vagal complex lowers glucose production.

Authors:  Carol K L Lam; Madhu Chari; Brenda B Su; Grace W C Cheung; Andrea Kokorovic; Clair S Yang; Penny Y T Wang; Teresa Y Y Lai; Tony K T Lam
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

3.  Atypical transforming growth factor-β signaling in the hypothalamus is linked to diabetes.

Authors:  Eliana P Araujo; Claudio T de Souza; Licio A Velloso
Journal:  Nat Med       Date:  2014-09       Impact factor: 53.440

4.  Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice.

Authors:  D Song; R H J Bandsma; C Xiao; L Xi; W Shao; T Jin; G F Lewis
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

5.  Short-term interval training alters brain glucose metabolism in subjects with insulin resistance.

Authors:  Sanna M Honkala; Jarkko Johansson; Kumail K Motiani; Jari-Joonas Eskelinen; Kirsi A Virtanen; Eliisa Löyttyniemi; Juhani Knuuti; Pirjo Nuutila; Kari K Kalliokoski; Jarna C Hannukainen
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-29       Impact factor: 6.200

6.  Duodenal-Jejunal Bypass Ameliorates Type 2 Diabetes Mellitus by Activating Insulin Signaling and Improving Glucose Utilization in the Brain.

Authors:  Na Li; Qing-Tao Yan; Qi Jing; Rui-Yan Pan; Huai-Jie Wang; Bin Jiang; Xian-Jun Li; Yi Wang; Jun-Hong Dong; Xue-Jian Wang; Mei-Jia Zhang; Qing-Guo Meng; Xiang-Zhen Li; Zhi-Jun Liu; Zhi-Qin Gao; Mei-Hua Qu
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

7.  Crosstalk between circadian rhythmicity, mitochondrial dynamics and macrophage bactericidal activity.

Authors:  Jacqueline Oliva-Ramírez; María Maximina B Moreno-Altamirano; Benjamín Pineda-Olvera; Patricia Cauich-Sánchez; F Javier Sánchez-García
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 8.  The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.

Authors:  Xinfu Guan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

9.  Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans.

Authors:  Juliet F Zechner; Uyenlinh L Mirshahi; Santhosh Satapati; Eric D Berglund; Jari Rossi; Michael M Scott; Christopher D Still; Glenn S Gerhard; Shawn C Burgess; Tooraj Mirshahi; Vincent Aguirre
Journal:  Gastroenterology       Date:  2012-11-15       Impact factor: 22.682

Review 10.  Sugar for the brain: the role of glucose in physiological and pathological brain function.

Authors:  Philipp Mergenthaler; Ute Lindauer; Gerald A Dienel; Andreas Meisel
Journal:  Trends Neurosci       Date:  2013-08-20       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.